Xtant Medical Holdings, Inc. - Common Stock (XTNT)
CUSIP: 98420P308
Q4 2018 13F Holders as of 31 Dec 2018
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 140,036,400
- Total 13F shares
- 11,735,030
- Share change
- +43,468
- Total reported value
- $18,894,000
- Price per share
- $1.61
- Number of holders
- 11
- Value change
- +$69,173
- Number of buys
- 4
- Number of sells
- 3
Quarterly Holders Quick Answers
What is CUSIP 98420P308?
CUSIP 98420P308 identifies XTNT - Xtant Medical Holdings, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 98420P308:
Top shareholders of XTNT - Xtant Medical Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
6.6%
|
9,207,012
|
$35,447,000 | — | 30 Sep 2018 | |
| Park West Asset Management LLC |
13F
|
Company |
0.9%
|
1,258,733
|
$4,846,000 | — | 30 Sep 2018 | |
| Telemetry Investments, L.L.C. |
13F
|
Company |
0.52%
|
733,747
|
$2,825,000 | — | 30 Sep 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.26%
|
368,105
|
$1,417,000 | — | 30 Sep 2018 | |
| Bruce & Co., Inc. |
13F
|
Company |
—
class O/S missing
|
182,972
|
$704,000 | — | 30 Sep 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
50,348
|
$194,000 | — | 30 Sep 2018 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
50,000
|
$193,000 | — | 30 Sep 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
10,824
|
$42,000 | — | 30 Sep 2018 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
10,474
|
$41,000 | — | 30 Sep 2018 | |
| Winslow, Evans & Crocker, Inc. |
13F
|
Company |
0%
|
1,258
|
$6,000 | — | 30 Sep 2018 | |
| UBS Group AG |
13F
|
Company |
0%
|
728
|
$3,000 | — | 30 Sep 2018 | |
| First Horizon Advisors, Inc. |
13F
|
Company |
0%
|
333
|
$1,000 | — | 30 Sep 2018 |
Institutional Holders of Xtant Medical Holdings, Inc. - Common Stock (XTNT) as of Q4 2018
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2018 vs Q3 2018 Across Filers
| Investor | Q3 2018 Shares | Q4 2018 Shares | Share Diff | Share Chg % | Q3 2018 Value $ | Q4 2018 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.